Kharchenko V P, Voznyĭ E K, Galil-Ogly G A, Gurov S N, Dobrovol'skaia N I, Alinchenko L A, Bol'shakova S A
Russian Center for Roentgenology Research, Ministry of Health of the RF, Moscow.
Vopr Onkol. 2000;46(6):740-4.
A correlation was established between the end-results of neoadjuvant chemotherapy for locally-advanced breast cancer and pathological response of tumor cells. Also, the end-results correlated with CR or PR and pathological response. Only a small proportion of patients with tumor progression were registered as stage III or IV of pathological response (0.6 and 0.8%, respectively).
局部晚期乳腺癌新辅助化疗的最终结果与肿瘤细胞的病理反应之间建立了相关性。此外,最终结果与完全缓解(CR)或部分缓解(PR)及病理反应相关。只有一小部分肿瘤进展的患者被登记为病理反应的III期或IV期(分别为0.6%和0.8%)。